96 related articles for article (PubMed ID: 7817936)
1. DNA and PCNA content of renal cell carcinoma and prognosis.
Flint A; Grossman HB; Liebert M; Lloyd RV; Bromberg J
Am J Clin Pathol; 1995 Jan; 103(1):14-9. PubMed ID: 7817936
[TBL] [Abstract][Full Text] [Related]
2. Expression of proliferating cell nuclear antigen and deoxyribonucleic acid value in renal cell carcinoma: correlation with different histopathological parameters and patient survival.
Shameem IA; Shimabukuro T; Wada T; Kurisu H; Naito K
Eur Urol; 1996; 29(1):78-84. PubMed ID: 8821696
[TBL] [Abstract][Full Text] [Related]
3. [Proliferating cell nuclear antigen expression as a prognostic indicator for renal cell carcinoma: comparison with pathologic features and DNA content].
Nakano S; Kawamura J
Hinyokika Kiyo; 1995 May; 41(5):343-8. PubMed ID: 7598033
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
5. [Qualitative and quantitative parameters for prognosis in renal carcinoma in early and advanced stages].
Del Vecchio MT; Spina D; Lazzi S; Bruni A; Funtò I; Mattei FM; Fornaini M; Luzi P; Tosi P
Pathologica; 1997 Aug; 89(4):390-6. PubMed ID: 9471607
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index.
Grignon DJ; Abdel-Malak M; Mertens W; Koster J; Keeney M; Sakr W; Shepherd RR
Mod Pathol; 1995 Jan; 8(1):18-24. PubMed ID: 7731937
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome in localized renal cell carcinomas related to immunoexpression of proliferating cell nuclear antigen, Ki-67 antigen, and tumor size.
Onda H; Yasuda M; Serizawa A; Osamura RY; Kawamura N
Oncol Rep; 1999; 6(5):1039-43. PubMed ID: 10425300
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of DNA ploidy, AgNORs, PCNA and c-erbB-2 as predictors of prognosis in patients with renal cell carcinoma].
Tamaki M; Maeda S; Deguchi T; Kawada Y
Hinyokika Kiyo; 1997 Oct; 43(10):697-702. PubMed ID: 9395903
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen expression in renal cell carcinoma. Prognostic implications.
Larsson P; Roos G; Stenling R; Ljungberg B
Scand J Urol Nephrol; 1996 Dec; 30(6):445-50. PubMed ID: 9008023
[TBL] [Abstract][Full Text] [Related]
10. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in renal cell carcinoma.
Morell-Quadreny L; Clar-Blanch F; Fenollosa-Enterna B; Perez-Bacete M; Martinez-Lorente A; Llombart-Bosch A
Anticancer Res; 1998; 18(1B):677-82. PubMed ID: 9584051
[TBL] [Abstract][Full Text] [Related]
12. Intranuclear localization of proliferating cell nuclear antigen during the cell cycle in renal cell carcinoma.
Kawamura K; Kobayashi Y; Tanaka T; Ikeda R; Fujikawa-Yamamoto K; Suzuki K
Anal Quant Cytol Histol; 2000 Apr; 22(2):107-13. PubMed ID: 10800611
[TBL] [Abstract][Full Text] [Related]
13. Assessment of proliferating cell nuclear antigen expression and prognosis in patients with renal cell carcinoma with pulmonary metastases.
Gotoh A; Hanioka K; Shirakawa T; Wada Y; Gohji K; Okada H; Arakawa S; Kamidono S
Int J Urol; 1998 May; 5(3):214-8. PubMed ID: 9624550
[TBL] [Abstract][Full Text] [Related]
14. [DNA ploidy pattern, p53 immunohistochemical overexpression and PCNA labeling index in "single nodular" human hepatocellular carcinomas from the viewpoint of biological malignant potential].
Saiki I; Une Y; Uchino J
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():103-9. PubMed ID: 7611770
[TBL] [Abstract][Full Text] [Related]
15. Biological and clinical implication of cellular DNA content in renal cell carcinomas.
Di Silverio F; Gallucci M; Flammia GP; De Vico A; Caponera M; Eleuteri P; Forte D; Cavallo D; De Vita R
Eur Urol; 1992; 21 Suppl 1():43-7. PubMed ID: 1425835
[TBL] [Abstract][Full Text] [Related]
16. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
17. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
[TBL] [Abstract][Full Text] [Related]
18. Papillary renal cell carcinoma: clinical implication of DNA content analysis.
el-Naggar AK; Ro JY; Ensign LG
Hum Pathol; 1993 Mar; 24(3):316-21. PubMed ID: 8454276
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy of oncocytic-granular renal cell carcinomas and renal oncocytomas by image analysis.
Veloso JD; Solis OG; Barada JH; Fisher HA; Ross JS
Arch Pathol Lab Med; 1992 Feb; 116(2):154-8. PubMed ID: 1733409
[TBL] [Abstract][Full Text] [Related]
20. [Expression of proliferating cell nuclear antigen (PCNA) in renal cell carcinoma].
Seki H; Nagamori S; Koyanagi T
Nihon Hinyokika Gakkai Zasshi; 1995 Sep; 86(9):1475-82. PubMed ID: 7474637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
